LeMaitre Vascular president plans Dec. 31 retirement

David B. Roberts intends to remain on LeMaitre Vascular’s board after retiring as president, with his director term ending in 2029.

Rhea-AI Filing Summary

LeMaitre Vascular, Inc. says David B. Roberts notified the company on October 9, 2026, of his intent to retire as an employee, including as president, effective December 31, 2026. Roberts was reelected as a director at the 2026 Annual Meeting of Stockholders for a term ending in 2029 and intends to continue serving on the Board after retiring as president. The company thanked him for 29 years of executive service.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Figures

Retirement effective date: December 31, 2026 Director term ends: 2029 Executive service: 29 years

3 metrics

Retirement effective date December 31, 2026 Roberts’ intended retirement as an employee, including as president

Director term ends 2029 Term following reelection at the 2026 Annual Meeting of Stockholders

Executive service 29 years Service recognized by the company

Key Terms

forward-looking statements, Private Securities Litigation Reform Act of 1995, Risk Factors

3 terms

forward-looking statements regulatory

"contains forward-looking statements"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

Private Securities Litigation Reform Act of 1995 regulatory

"within the meaning of the U.S. Private Securities Litigation Reform Act of 1995"

Risk Factors regulatory

"under the heading “Risk Factors”"

Risk factors are elements or conditions that could cause an investment's value to decrease or lead to potential losses. They are like warning signs or obstacles that can affect the success of an investment, making it uncertain or more unpredictable. Recognizing risk factors helps investors understand the possible challenges and make more informed decisions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is LMAT President David B. Roberts retiring?

David B. Roberts intends to retire as a LeMaitre Vascular employee, including as president, effective December 31, 2026. He also intends to continue serving on the Board of Directors after his retirement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/15/2026 - 04:11 PM EDT Accepted by SEC EDGAR 10/15/2026 - 04:11 PM EDT Learn about SEC filing dates

0001158895false00011588952026-10-092026-10-09

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 09, 2026

LeMaitre Vascular, Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware			001-33092	04-2825458
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
63 Second Avenue
Burlington, Massachusetts				01803
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: 781 221-2266

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, $0.01 par value per share		LMAT		The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On October 9, 2026, David B. Roberts notified LeMaitre Vascular, Inc. (the “Company”) of his intent to retire as an employee of the Company, including as its President, effective as of December 31, 2026. Mr. Roberts was reelected as a director at the Company’s 2026 Annual Meeting of Stockholders for a term ending in 2029, and Mr. Roberts intends to continue to serve on the Company’s Board of Directors following his retirement as President.

The Company thanks Mr. Roberts for his 29 years of executive service and is pleased to retain his Board-level services going forward.

Forward-Looking Statements

This current report on Form 8-K contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Statements regarding the Company’s business that are not historical facts may be “forward-looking statements” that involve risks and uncertainties. Forward-looking statements are based on management’s current, preliminary expectations and are subject to risks and uncertainties that could cause actual results to differ from the results predicted. These risks and uncertainties include risks and uncertainties included under the heading “Risk Factors” in the Company’s most recent Annual Report on Form 10-K, as updated by its subsequent filings with the SEC, all of which are available on the Company’s investor relations website at http://www.lemaitre.com and on the SEC’s website at http://www.sec.gov. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. The Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			LEMAITRE VASCULAR, INC.
Date:	October 15, 2026	By:	/s/Dorian P. LeBlanc
			Name: Dorian P. LeBlanc Title: Chief Financial Officer

Filing Exhibits & Attachments

1 document

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 23.3 KB